Form 4 for LONA LeonaBio, Inc.
Accepted 2022-02-18 00:00:00 ET · period of report 2022-02-18 · accession 0001209191-22-011485 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-18 | 2022-02-18 | LONA | CHURCH KEVIN | Executive VP, Research | M - OptEx | $1.19 | +3,152 | 47.6K | +7% | +$3,751 |
| D | 2022-02-18 | 2022-02-18 | LONA | CHURCH KEVIN | Executive VP, Research | M - OptEx | $0.00 | -3,152 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-18 | M | A | 3,152 | $1.19 | 47,566 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-02-18 | M | D | 3,152 | $0.00 | 0 | D | $1.19 · — to 2027-06-18 | 3,152 Common Stock | (F1) The shares subject to the option fully vested on September 1, 2017. |